{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:00:52Z","timestamp":1787238052596,"version":"build-2736575974"},"reference-count":24,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CNSNDDT"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract:<\/jats:title>\n                    <jats:p>G-protein-coupled receptors (GPCRs) are activated by manifold neurotransmitters, and their\nactivation, in turn, evokes slow synaptic transmission. They are profoundly related to numerous psychiatric\nand neurological disorders such as schizophrenia and Parkinson's disease. The significant malady\nindications for GPCR modulators demonstrate a change towards obesity, diabetes, and Alzheimer's\ndisease, while other central nervous system disorders persist highly represented. GPR52, GPR6,\nand GPR8 are recognised as orphan GPCRs, co-exist either with both the dopamine D2 and D1 receptors\nin neurons of the basal ganglia or with the dopamine D2 receptor alone, and recommend that between\nthese orphan receptors, GPR52 has the maximum potential of being a therapeutic psychiatric\nreceptor. Genetically modified creature models and molecular biological investigations have suggested\nthat these improved GPCRs could be potential therapeutic psychiatric receptors. In this perspective,\nthe role of molecular targets in GPCR-mediated signalling has been discussed that would be novel\ndrug design and discovery options for a scientist to elaborate previous knowledge with modern techniques.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1871527321666220430142722","type":"journal-article","created":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T08:44:06Z","timestamp":1652085846000},"page":"2-5","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Role of G-Proteins and GPCR-Mediated Signalling in Neuropathophysiology"],"prefix":"10.2174","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0088-0565","authenticated-orcid":true,"given":"Mohammad Amjad","family":"Kamal","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh"},{"name":"King Fahd Medical Research Center, King Abdulaziz University, Saudi Arabia"},{"name":"Institutes for Systems Genetics,\nFrontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu\n610041, Sichuan, Chinaa"},{"name":"Enzymoics; Novel Global Community Educational Foundation, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Mominur","family":"Rahman","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia Afsana","family":"Mim","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Rezaul","family":"Islam","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrin","family":"Sultana","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muniruddin","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.cmet.2017.03.008","volume":"25","author":"Husted A.S.","year":"2017","unstructured":"Husted A.S.; Trauelsen M.; Rudenko O.; GPCR-mediated signaling of metabolites. Cell Metab 2017,25(4),777-796","journal-title":"Cell Metab"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.neuron.2008.09.004","volume":"59","author":"Agulhon C.","year":"2008","unstructured":"Agulhon C.; Petravicz J.; McMullen A.B.; What is the role of astrocyte calcium in neurophysiology? Neuron Cell Press 2008,59(6),932-946","journal-title":"Neuron Cell Press"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.phrs.2016.06.026","volume":"111","author":"Khan SM","year":"2016","unstructured":"Khan SM; Sung JY; H&#xE9;bert TE.; G&#x3B2;&#x3B3; subunits-Different spaces, different faces J Pharma Res 2016,111,434-441","journal-title":"J Pharma Res"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4062\/biomolther.2016.165","volume":"25","author":"Bologna Z.","year":"2017","unstructured":"Bologna Z.; Teoh J.P.; Bayoumi A.S.; Tang Y.; Kim I.M.; Biased g protein-coupled receptor signaling: New player in modulating physiology and pathology. Biomol Ther (Seoul) 2017,25(1),12-25","journal-title":"Biomol Ther (Seoul)"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"216","DOI":"10.2174\/1566523221666210303100805","volume":"21","author":"Rahman M.M.","year":"2021","unstructured":"Rahman M.M.; Ferdous K.S.; Ahmed M.; Hutchinson-gilford progeria syndrome: An overview of the molecular mechanism, pathophysiology and therapeutic approach. Curr Gene Ther Bentham Science Publishers Ltd 2021,21(3),216-229","journal-title":"Curr Gene Ther Bentham Science Publishers Ltd"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1001\/archpsyc.1982.04290070059011","volume":"39","author":"Goldberg D.","year":"1982","unstructured":"Goldberg D.; Steele J.J.; Johnson A.; Smith C.; Ability of primary care physicians to make accurate ratings of psychiatric symptoms. Arch Gen Psychiatry 1982,39(7),829-833","journal-title":"Arch Gen Psychiatry"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1001\/archpsyc.1985.01790290065007","volume":"42","author":"Kessler L.G.","year":"1985","unstructured":"Kessler L.G.; Cleary P.D.; Burke J.D.; Psychiatric disorders in primary care. Results of a follow-up study. Arch Gen Psychiatry 1985,42(6),583-587","journal-title":"Arch Gen Psychiatry"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0193-953X(18)30845-1","volume":"6","author":"Jefferson J.W.","year":"1983","unstructured":"Jefferson J.W.; Treating affective disorders in the presence of cardiovascular disease. Psychiatr Clin North Am 1983,6(1),141-155","journal-title":"Psychiatr Clin North Am"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1056\/NEJM198408233110805","volume":"311","author":"Cassileth B.R.","year":"1984","unstructured":"Cassileth B.R.; Lusk E.J.; Strouse T.B.; Psychosocial status in chronic illness. N Engl J Med Massachusetts Med Soc 1984,311(8),506-511","journal-title":"N Engl J Med Massachusetts Med Soc"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3390\/biology11010147","volume":"11","author":"Rahman M.M.","year":"2022","unstructured":"Rahman M.M.; Islam M.R.; Islam M.T.; Stem cell transplantation therapy and neurological disorders: Current status and future perspectives. Biology 2022,11(1),147","journal-title":"Biology"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3390\/molecules27010233","volume":"27","author":"Rahman M.M.","year":"2021","unstructured":"Rahman M.M.; Rahaman M.S.; Islam M.R.; Role of phenolic compounds in human disease: Current knowledge and future prospects. Molecules 2021,27(1),233","journal-title":"Molecules"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.pharmthera.2003.11.002","volume":"101","author":"Nichols D.E.","year":"2004","unstructured":"Nichols D.E.; Hallucinogens. Pharmacol Ther 2004,101(2),131-181","journal-title":"Pharmacol Ther"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1080\/02791072.2017.1320734","volume":"49","author":"Thomas K.","year":"2017","unstructured":"Thomas K.; Malcolm B.; Lastra D.; Psilocybin-assisted therapy: A review of a novel treatment for psychiatric disorders. J Psychoactive Drugs Routledge 2017,49(5),446-455","journal-title":"J Psychoactive Drugs Routledge"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.psychres.2015.03.038","volume":"227","author":"Newton D.F.","year":"2015","unstructured":"Newton D.F.; Naiberg M.R.; Goldstein B.I.; Oxidative stress and cognition amongst adults without dementia or stroke: Implications for mechanistic and therapeutic research in psychiatric disorders. Psychiatry Res 2015,227(2-3),127-134","journal-title":"Psychiatry Res"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1515\/BC.2003.059","volume":"384","author":"Dringen R.","year":"2003","unstructured":"Dringen R.; Hirrlinger J.; Glutathione pathways in the brain. Biol Chem 2003,384(4),505-516","journal-title":"Biol Chem"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"685","DOI":"10.2165\/00002512-200118090-00004","volume":"18","author":"Halliwell B.","year":"2001","unstructured":"Halliwell B.; Role of free radicals in the neurodegenerative diseases: Therapeutic implications for antioxidant treatment. Drugs Aging 2001,18(9),685-716","journal-title":"Drugs Aging"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.biopsych.2003.12.012","volume":"55","author":"Karry R.","year":"2004","unstructured":"Karry R.; Klein E.; Ben Shachar D.; Mitochondrial complex I subunits expression is altered in schizophrenia: A postmortem study. Biol Psychiatry 2004,55(7),676-684","journal-title":"Biol Psychiatry"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1523\/JNEUROSCI.3602-07.2008","volume":"28","author":"Chen L.","year":"2008","unstructured":"Chen L.; Ding Y.; Cagniard B.; Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice. J Neurosci 2008,28(2),425-433","journal-title":"J Neurosci"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/syn.20458","volume":"62","author":"Larouche A.","year":"2008","unstructured":"Larouche A.; Berube P.; Sarret P.; Grignon S.; Subacute H2O2, but not poly(IC), upregulates dopamine D2 receptors in retinoic acid differentiated SH-SY5Y neuroblastoma. Synapse 2008,62(1),70-73","journal-title":"Synapse"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1007\/s11064-008-9670-4","volume":"33","author":"Jia Z.","year":"2008","unstructured":"Jia Z.; Zhu H.; Misra B.R.; Li Y.; Misra H.P.; Dopamine as a potent inducer of cellular glutathione and NAD(P)H:quinone oxidoreductase 1 in PC12 neuronal cells: A potential adaptive mechanism for dopaminergic neuroprotection. Neurochem Res 2008,33(11),2197-2205","journal-title":"Neurochem Res"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1503\/jpn.100057","volume":"36","author":"Dean O.","year":"2011","unstructured":"Dean O.; Giorlando F.; Berk M.; N-acetylcysteine in psychiatry: Current therapeutic evidence and potential mechanisms of action. J Psychiatry Neurosci 2011,36(2),78-86","journal-title":"J Psychiatry Neurosci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"923","DOI":"10.2146\/ajhp140732","volume":"72","author":"Racz R","year":"2015","unstructured":"Racz R; Sweet BV; Sohoni P; Oral acetylcysteine for neuropsychiatric disorders. Am J Heal Pharm Am Soc Health-Systems Pharm 928-929.2015,72(11),923-926","journal-title":"Am J Heal Pharm Am Soc Health-Systems Pharm"},{"key":"ref=23","first-page":"2469486","volume":"2018","author":"Ooi S.L.","year":"2018","unstructured":"Ooi S.L.; Green R.; Pak S.C.; N-Acetylcysteine for the treatment of psychiatric disorders: A review of current evidence. BioMed Res Int 2018,2018,2469486","journal-title":"BioMed Res Int"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cell.2014.02.042","volume":"157","author":"Krystal J.H.","year":"2014","unstructured":"Krystal J.H.; State M.W.; Psychiatric disorders: Diagnosis to therapy. Cell 2014,157(1),201-214","journal-title":"Cell"}],"container-title":["CNS &amp; Neurological Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871527321666220430142722","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/204305\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871527321666220430142722","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T02:41:40Z","timestamp":1676515300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/204305\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871527321666220430142722","relation":{},"ISSN":["1871-5273"],"issn-type":[{"value":"1871-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-09-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}